Evidence map›Paper›PMID 36430685›Full record

ArticleInternational journal of molecular sciences2022

Anti-Proliferative Effects of Iridoids from

Hayato Yoshikawa, Takahiro Matsumoto, Takahiro Kitagawa, Masaya Okayama, Tomoe Ohta, Tatsusada Yoshida, Tetsushi Watanabe

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
13.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Hayato YoshikawaDepartment of Public Health, Kyoto Pharmaceutical University, 1 Misasagi-Shichono-cho, Yamashina-ku, Kyoto 607-8412, Japan.
Takahiro MatsumotoDepartment of Public Health, Kyoto Pharmaceutical University, 1 Misasagi-Shichono-cho, Yamashina-ku, Kyoto 607-8412, Japan.ORCID 0000-0003-2408-669X
Takahiro KitagawaDepartment of Public Health, Kyoto Pharmaceutical University, 1 Misasagi-Shichono-cho, Yamashina-ku, Kyoto 607-8412, Japan.
Masaya OkayamaDepartment of Public Health, Kyoto Pharmaceutical University, 1 Misasagi-Shichono-cho, Yamashina-ku, Kyoto 607-8412, Japan.
Tomoe OhtaFaculty of Pharmaceutical Sciences, Nagasaki International University, Nagasaki 859-3298, Japan.ORCID 0000-0002-4698-651X
Tatsusada YoshidaFaculty of Pharmaceutical Sciences, Nagasaki International University, Nagasaki 859-3298, Japan.
Tetsushi WatanabeDepartment of Public Health, Kyoto Pharmaceutical University, 1 Misasagi-Shichono-cho, Yamashina-ku, Kyoto 607-8412, Japan.
Kyoto Pharmaceutical University · JPNagasaki International University · JP

Funding

Japan Society for the Promotion of Science JP20H03397
6 · The paper itself

Abstract

We isolated seven new iridoid glucosides (valerianairidoids I-VII;

Indexed as

NeoplasmsValerianHumansIridoid GlucosidesIridoidsNeoplastic Stem CellsPlant RootsIridoid GlucosidesIridoidscancer preventioncancer stem cellcancer treatmentECDValeriana faurieivalerianairidoid

Identifiers

PMID36430685
PMCPMC9698980
OpenAlexW4309171732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.